Publications
36
Citations
324
Est. group size
~4
Recurring co-author estimate
Active years
42
Publishing since 1985
Samara L. Potter's work focuses on pediatric and rare cancers, including thyroid carcinoma, brain and solid tumors, and hereditary cancer syndromes like Lynch syndrome in children. Much of the research involves molecular and genetic profiling of tumors (using DNA/RNA sequencing and circulating tumor DNA) to identify treatable mutations, as well as clinical trials testing new drug combinations for colon and thyroid cancers. This work is often conducted through large collaborative research networks such as the Children's Oncology Group.
Publication output has been variable but shows a general increase over the last decade, rising from about 1 paper per year in 2017 to a peak of 6 in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
New England Journal of Medicine · 2026
- Raising Awareness of Tremendous Progress and Ongoing Challenges in the Fight against Childhood and Adolescent Cancers
Cancer Discovery · 2026
- Selpercatinib Increases Radioactive Iodine Avidity in <i>RET</i> -Fusion Pediatric Thyroid Carcinoma
PEDIATRICS · 2025
- 752P Clinical outcome of patients (pts) with sporadic vs Lynch syndrome-related stage III colon carcinoma (CC) with deficient mismatch repair (dMMR) treated in a randomized trial of adjuvant FOLFOX alone or combined with atezolizumab (atezo; anti-PD-L1)
Annals of Oncology · 2025
- Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors Committee
Pediatric Blood & Cancer · 2025
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).
Journal of Clinical Oncology · 2025
- Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective
EJC Paediatric Oncology · 2023
- Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study
Pediatric Hematology and Oncology · 2023
- Frequency and spectrum of clinically significant molecular alterations detected by tumor gene panel testing for pediatric cancer patients in the Texas KidsCanSeq study.
Journal of Clinical Oncology · 2023
- Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study
Figshare · 2023
- Clinical and molecular features of pediatric cancer patients with Lynch syndrome
Pediatric Blood & Cancer · 2022
- Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board
Pediatric Hematology and Oncology · 2022
- Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
Pediatric Blood & Cancer · 2021
- Clinical and molecular features of pediatric cancer patients with Lynch syndrome
Molecular Genetics and Metabolism · 2021
- Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma
Pediatric Blood & Cancer · 2020
- Pediatric Blood & Cancer×6
- Journal of Clinical Oncology×3
- Neuro-Oncology×3
- Pediatric Hematology and Oncology×2
- Oncology Times×2
- Brian Weiss
Medicine · Indiana University
- Daniel R. Boué
Medicine · The Ohio State University
- Jennifer H. Aldrink
Medicine · The Ohio State University
- Jennifer Sturgis
Medicine · Purdue University West Lafayette
- Jonathan L. Finlay
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile